SEBI Drops Rs 3,912-Crore Case Against Max, Axis Bank; Finds No Proof Of Fraud

In a major reprieve for Max Financial Services Ltd. (MFSL) and Axis Bank Ltd., the Securities and Exchange Board of India (SEBI) has dismissed a sweeping set of allegations that accused the financial giants of orchestrating a Rs. 3,912 crore fraudulent scheme.

The markets regulator disposed of the proceedings against MFSL, Axis Bank, Max Life Insurance Company (MLIC), Axis Capital, Axis Securities, and several key managerial personnel, concluding that a regulatory arbitrage under insurance laws does not automatically equate to securities fraud.

The complex case, which spans over a decade of corporate dealmaking, probed whether a series of structured equity transactions between 2010 and 2021 were deliberately designed to bypass insurance commission caps, thereby defrauding MFSL shareholders.

ALSO READ | SEBI Launches Cyber Suraksha Portal To Strengthen Securities Market Cybersecurity

The Genesis: An IRDAI Trigger

The regulatory scrutiny originally stemmed from the Insurance Regulatory and Development Authority of India (IRDAI). In November 2022, IRDAI informed SEBI that MFSL and Axis Bank had engaged in a series of buy-and-sell transactions in the unlisted equity shares of Max Life.

IRDAI had previously fined Axis Bank Rs.2 crore and Max Life Rs. 3 crore, ruling that the entities had circumvented maximum commission limits by structuring equity transfers disguised as investments. Specifically, Axis Bank was repeatedly issued Max Life shares at par value (Rs. 10), which MFSL and its partners later bought back at significant premiums-ranging from Rs. 54 to Rs.166 per share-linked to fair market value.

SEBI's subsequent Show Cause Notice (SCN) alleged that these deals were a consolidated scheme to illegally compensate Axis Bank for its bancassurance partnership, causing an alleged loss of Rs. 3,911.95 crore to MFSL and enriching Axis Group entities. SEBI also alleged that MFSL made incomplete and misleading disclosures to the stock exchanges by failing to reveal the underlying put and call options of these deals.

The Verdict: Sectoral Arbitrage vs. Securities Fraud

In his final order, SEBI Whole Time Member Amarjeet Singh dismantled the SCN's core premise that an insurance regulation violation inherently translates to a violation of the SEBI Act and the Prevention of Fraudulent and Unfair Trade Practices (PFUTP) Regulations.

Addressing the jurisdictional overlap and the nature of the fraud charges, the SEBI order provides a striking analytical distinction between circumventing sectoral caps and defrauding public shareholders:

"While the structuring of this transaction was later deemed by IRDAI to be a regulatory circumvention of insurance commission limits, this constitutes a regulatory arbitrage falling squarely within the domain of insurance laws. [...] Without independent evidence demonstrating that the valuations were falsely reported to the stock exchanges to manipulate MFSL's scrip price, a penalty by another regulator for sector-specific cap violations cannot automatically be imported as a 'fraudulent and unfair trade practice'."

SEBI observed that the pricing mechanisms, issuance at par and repurchase at a higher price, were actually submitted to and approved by IRDAI in 2016, and were disclosed in MFSL's financial statements. Furthermore, SEBI emphasised that to prove fraud under securities law, there must be evidence of "inducement" or market manipulation.

The regulator found no evidence that MFSL shareholders were induced to trade based on false premises, or that the stock price was artificially inflated. Concluding the fraud analysis, the order stated:

"The SCN has neither established injury arising from the alleged wrongful acts, including inducement to deal in securities, nor demonstrated such blatant conduct or attending circumstances that would establish a wrongful intention to defraud or manipulate the securities market."

The Disclosure Dilemma: Judging the Past with the "Benefit of Hindsight"

A significant portion of SEBI's analysis focused on whether MFSL illegally concealed the put and call options embedded in the 2010 and 2015 arrangements. SEBI noted that while MFSL disclosed the primary issuance of shares to Axis Bank, it selectively omitted the simultaneous buy-back agreements initially.

However, SEBI adopted a pragmatic view of the evolving nature of Indian disclosure laws. The transactions prior to December 2015 were governed by the erstwhile Listing Agreement, which lacked quantitative thresholds for "materiality," unlike the modern LODR (Listing Obligations and Disclosure Requirements) Regulations.

While noting that MFSL's initial disclosures "presented only an incomplete picture of the composite transaction," the regulator refused to penalise the company retrospectively. SEBI analytical reasoning highlights the danger of applying modern standards to past actions:

"Viewed with the benefit of this evolved framework, the disclosures made by MFSL could undoubtedly have been more comprehensive and, in certain instances, a more cautious and consistent approach to disclosure may have been desirable. However, the conduct of MFSL and other Noticees has to be tested against the legal requirements prevailing at the relevant time."

Because the SCN failed to demonstrate exactly how the omitted details specifically impacted MFSL's operations or price discovery at the time, the disclosure charges were dropped.

ALSO READ | SEBI Introduces IT Resilience Index For Market Infrastructure Institutions

Exoneration of Key Executives

With the primary charges of fraud and disclosure violations against the corporate entities collapsing, SEBI also dropped all vicarious liability charges against the company's Key Managerial Personnel (KMPs).

The notices had targeted prominent executives, including Founder Chairman Analjit Singh, Managing Director Mohit Talwar, and several Chief Financial Officers, alleging they failed in their fiduciary duties. SEBI ruled that without a foundational contravention by the company, and without evidence of specific, individual malicious acts by the executives, vicarious liability could not be applied.

The dismissal of the SCN closes a major regulatory overhang for both Max Financial and Axis Bank. The bancassurance partnership, which began in 2010, transformed Max Life into a major industry player, with its embedded value surging from Rs. 3,200 crore in FY11 to over Rs. 24,000 crore recently. Axis Bank is now formally a co-promoter of Max Life.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.